Introduction to AAV Gene Therapies
Today Headline,
Recombinant adeno-associated viral vectors are the leading platform for treating human diseases through gene delivery.
Recombinant adeno-associated viral vectors are the leading platform for treating human diseases through gene delivery.
Immunogenicity is the ability of a substance, such as a foreign and/or potentially dangerous protein, to provoke an antigen-speci…
STOCKHOLM - (publ) (Sobi) (STO: SOBI) and (Nasdaq: SELB) today announced the commencement of the phase 3 clinical programme of…
STOCKHOLM and WATERTOWN, Mass., Sept. 23, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and…